Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

I am, dear. I am John Rambo. Doctors don’t fully understand quite how semaglutides work, but they do have a good sketch of what they do. These drugs are known as GLP-1 agonists. GLP-1 is a naturally ...

FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as ...

Study: Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time ... These results suggest that GLP-1 RA use does not increase the risk of suicidal behaviors, even ...

Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and musculoskeletal issues Study ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Kidney stones are among the possible risks of GLP-1 use that were not previously known. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may have a wider range of benefits and risks than what ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders. HealthDay News — For people with diabetes, the use of glucagon ...